Berkshire Hathaway and Tokio Marine Form Major Strategic Insurance Partnership 
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence 
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round 
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation 
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update 
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict 
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group 
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion 
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production 
Finnair Orders 18 Embraer E195-E2 Jets in Landmark Fleet Overhaul 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push 
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push 
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025 
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield 
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion 
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling 
Bayer AG has resolved about 88,500 of an estimated 125,000 filed and unfiled claims against its Roundup weedkiller, prompting US court-appointed mediator Kenneth Feinberg to report that the company had made substantial progress.
Feinberg noted that it is just a question of when and how quickly they’ll get resolved.”
The German company said it is fully committed to settling the litigations concerning the carcinogenic properties of Roundup.
Bayer inherited liability for the lawsuits over glyphosate-based Roundup, which it acquired along with its purchase of Monsanto for $63 billion in June 2018.
The acquisition made Bayer the world’s largest supplier of seeds and pesticides but its shares have since fallen 54 percent.
Bayer lost three trials for Roundup in 2018 and 2019.
In June, the company projected it would pay up to $10.9 billion to resolve existing claims and $1.25 billion for future claims. Last week, it increased the projected cost of future claims to $2 billion and took a $10.9 billion writedown in its crop science business.
